Europe's transparency vs privacy law: Titanic headed for iceberg?
This article was originally published in Scrip
The European Medicines Agency's policy on publication of trial data appears to be at odds, at least in spirit, with the broad direction of EU privacy law and the path ahead could potentially be strewn with litigation, a recent DIA conference in India heard.
You may also be interested in...
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
The head of global vaccine and plasma segments, bioprocessing, at German multinational Merck discusses key aspects around evolving vaccine manufacturing to improve the efficiency and speed of response during a pandemic. Pre-existing manufacturing platforms, the executive says, could compress process development work and fast-track scale-up.
Glenmark and Sun Pharma introduce nintedanib generics in India at a fraction of the innovator product’s price, vying for a share of the IPF market where pirfenidone currently holds sway.